Vimarsana
Biggest News Aggregation in the World

Rett Community News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rett Community. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rett Community Today - Breaking & Trending Today

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript - Vimarsana News

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

Published: February 29, 2024

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.

Source: insidermonkey.com
Related Topics:
United StatesUnited KingdomMark SchneyerParag MeswaniCharles DuncanTessa RomeroJoel BeattyAl KildaniSteve DavisDoug WilliamsonDavid HoangBrendan TeehanGregory RenzaAshwani VermaCorporate CommunicationsAmerican Epilepsy SocietyTrial Court LevelPharmaceuticals IncPharmaceuticals Fourth QuarterEuropean Medicines AgencyToronto Court LevelJapanese Regulatory AgencyHead Of ResearchRett Centers Of ExcellenceTrial Court
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript - Vimarsana News

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript

Published: November 4, 2023

Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.

Source: insidermonkey.com
Related Topics:
United StatesParag MeswaniGregory RenzaBrendan TeehanAlbert KildaniYatin SunejaTessa RomeroMark SchneyerDoug WilliamsonKathie BishopAl KildaniSteve DavisHealth CanadaPharmaceuticals Third QuarterRett CommunityAcadia Pharmaceuticals IncNeuron PharmaceuticalsHead Of ResearchCorporate CommunicationsCall Transcript NovemberThird QuarterResults ConferenceSenior Vice PresidentInvestor RelationsChief Executive Officer